|Other names||Iron isomaltoside 1000|
|Drug class||Iron preparation|
|Main uses||Iron deficiency anemia|
|Side effects||Rash, nausea, iron overload, infection, allergic reactions|
|US NLM||Ferric derisomaltose|
|Chemical and physical data|
|Molar mass||562.299 g·mol−1|
|3D model (JSmol)|
Ferric derisomaltose, sold under the brand name Monoferric, is a medication used to treat iron deficiency anemia (IDA). Specifically it is used in people who cannot take iron by mouth or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD). It is given by injection into a vein.
Common side effects include rash and nausea. Other side effects may iron overload, infection, and allergic reactions. Safety in pregnancy is unclear, and some recommend not using in the 1st trimester. It is an iron preparation.>
Ferric derisomaltose was approved for medical use in the United States in 2020. In the United Kingdom 1 gram costs the NHS about £170 in 2021. In the United States this amount costs about 2,600 USD.
For those over 50 kg, it is given as a dose of 1,000 mg while for those under 50 kg a dose of 20mg/kg is used.
- BNF 81: March-September 2021. BMJ Group and the Pharmaceutical Press. 2021. p. 1068. ISBN 978-0857114105.
- "Ferric Derisomaltose Monograph for Professionals". Drugs.com. Retrieved 10 December 2021.
- "Monoferric- ferric derisomaltose solution". DailyMed. 24 January 2020. Archived from the original on 1 October 2020. Retrieved 16 February 2020.
- "Ferric derisomaltose (Monoferric) Use During Pregnancy". Drugs.com. Retrieved 10 December 2021.
- "Monoferric Prices, Coupons & Patient Assistance Programs". Drugs.com. Retrieved 10 December 2021.